BridgeMD
Tests treatment safety and results for Moderate-to-severe Atopic Dermatitis
Official title A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov ID: NCT07211542
What this study is testing
What is SHR-1905 Injection?
SHR-1905 Injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for moderate-to-severe atopic dermatitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- The people have voluntarily signed the informed consent form prior to the start of any procedures related to the study, are able to communicate...
- At the time of signing the informed consent, the people are ≥ 18 years old and ≤ 75 years old, male or female.
- Have atopic dermatitis at screening.
You likely can't join if
- Hypersensitivity to the study drug or any ingredient in the study drug.
- Have other active skin disease or skin complications due to other conditions that may affect the evaluation of Atopic Dermatitis (AD).
- Has malignancy or has a history of malignancy.
- Have serious concomitant diseases and other conditions that the investigator considers inappropriate to participate in this trial.
- Females who are pregnant or lactating.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.